Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1454 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6781    
    Printed105    
    Emailed4    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 SHORT COMMUNICATION
Year : 1993  |  Volume : 59  |  Issue : 2  |  Page : 74--76

Treatment of acne vulgaris with oral tetracyclines


Correspondence Address:
Neena Khanna


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Forty four patients with moderately severe and severe acne were put on treatment with either tetracycline 1g daily (21 patients) or minocycline 100 mg daily (23 patients). Patients were assessed at 6 and 12 weeks by calculating the reduction of the acne lesion score. At 6 weeks with minocycline 47.6% of the patients showed a good response, with tetracycline none of the patients showed a comparable response and the difference in the 2 therapeutic groups was statistically significant (p<0.01). However, at 12 weeks the response of acne was comparable with the 2 drugs. With tetracycline 70.4% patients and with minocycline 69.6% patients showed a good to excellent response. Similarly, at 6 weeks the mean reduction in acne lesion score was significantly better with minocycline than with tetracycline, but at 12 weeks the response was comparable with the 2 drugs.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow